Livzon Pharmaceutical Group Inc. Report issue

For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Zhuhai China (1985)

Organization Overview

First Clinical Trial
2004
NCT00953381
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Livzon Pharmaceutical Group Inc.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Azoospermia (Phase 4)

Duodenal Ulcer (Phase 4)

Esophagitis, Peptic (Phase 3)

Gastroesophageal Reflux (Phase 3)

Hemorrhage (Phase 3)

Infections (Phase 4)

Neoplasms (Phase 1)

Oligospermia (Phase 4)

Peptic Ulcer (Phase 3)

Peptic Ulcer Hemorrhage (Phase 3)

Ulcer (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 26
  • # of Trial APIs: 23